| Stem definition | Drug id | CAS RN |
|---|---|---|
| 906 | 67-68-5 |
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| April 4, 1978 | FDA | MYLAN INSTITUTIONAL | |
| Jan. 22, 2021 | PMDA | Kyorin Pharmaceutical Co Ltd |
None
None
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Respiratory depression | 66.27 | 50.80 | 19 | 614 | 27611 | 79716144 |
None
| Source | Code | Description |
|---|---|---|
| ATC | G04BX13 | GENITO URINARY SYSTEM AND SEX HORMONES UROLOGICALS UROLOGICALS Other urologicals |
| ATC | M02AX03 | MUSCULO-SKELETAL SYSTEM TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN Other topical products for joint and muscular pain |
| MeSH PA | D000975 | Antioxidants |
| MeSH PA | D003451 | Cryoprotective Agents |
| MeSH PA | D016166 | Free Radical Scavengers |
| MeSH PA | D020011 | Protective Agents |
| MeSH PA | D012997 | Solvents |
| CHEBI has role | CHEBI:48358 | dipolar aprotic solvent |
| CHEBI has role | CHEBI:48578 | free radical scavengers |
| CHEBI has role | CHEBI:50247 | antidotes |
| CHEBI has role | CHEBI:76971 | Escherichia coli metabolites |
| CHEBI has role | CHEBI:176497 | geroprotectors |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Ulcerative cystitis | indication | 111409009 | DOID:13949 |
| Improvement of symptoms in patients with interstitial cystitis | indication | 197834003 | DOID:1678 |
| Disorder of lens | contraindication | 10810001 | DOID:110 |
| Kidney disease | contraindication | 90708001 | DOID:557 |
| Liver function tests abnormal | contraindication | 166603001 | |
| Malignant tumor of urinary tract proper | contraindication | 363517008 | |
| Urinary Burning Sensation | contraindication |
| Species | Use | Relation |
|---|---|---|
| Dogs | Acute swelling caused by trauma | Indication |
| Horses | Acute swelling caused by trauma | Indication |
| Product | Applicant | Ingredients |
|---|---|---|
| Domoso Solution | Zoetis Inc. | 1 |
| Synotic Otic Solution | Zoetis Inc. | 2 |
| Synsac Solution | Zoetis Inc. | 2 |
| Domoso Gel | Zoetis Inc. | 1 |
None
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Cereblon isoform 4 | Unclassified | Ki | 4.97 | CHEMBL |
| ID | Source |
|---|---|
| YOW8V9698H | UNII |
| 4019027 | VUID |
| N0000147300 | NUI |
| D01043 | KEGG_DRUG |
| 3455 | RXNORM |
| 4019027 | VANDF |
| C0012403 | UMLSCUI |
| CHEBI:28262 | CHEBI |
| DMS | PDB_CHEM_ID |
| CHEMBL504 | ChEMBL_ID |
| 679 | PUBCHEM_CID |
| DB01093 | DRUGBANK_ID |
| D004121 | MESH_DESCRIPTOR_UI |
| 2023 | INN_ID |
| 1614 | MMSL |
| 4608 | MMSL |
| d01431 | MMSL |
| 002883 | NDDF |
| 115535002 | SNOMEDCT_US |
| 346400003 | SNOMEDCT_US |
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| RIMSO-50 | HUMAN PRESCRIPTION DRUG LABEL | 1 | 67457-177 | IRRIGANT | 0.54 g | INTRAVESICAL | NDA | 15 sections |